Downregulation of c-FLIP expression has been shown to sensitize many cancer types to chemotherapy including cervical adenocarcinoma (Luo et al., 2008), breast (Rogers et al., 2007), colorectal (Longley et al., 2006), and prostate (Wilson et al., 2008). Here, CFLAR is linked to cancer.